Clinical trial
Docetaxel in Treating Patients With Advanced Cancer of the Cervix
NCT00003445 · Grupo Oncologico Cooperativo del Sur, Other · Completed
Key facts
| NCT number | NCT00003445 |
|---|---|
| Title | Docetaxel in Treating Patients With Advanced Cancer of the Cervix |
| Official title | Neoadjuvant Chemotherapy With Docetaxel in Advanced Cervical Carcinoma |
| Lead sponsor | Grupo Oncologico Cooperativo del Sur, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Cervical Cancer |
| Intervention type | Drug |
| Interventions | docetaxel |
| Start date | Dec 1, 1997 |
| Completion | Apr 1, 2004 |
| First posted | Apr 23, 2004 |
| Last update posted | Jun 26, 2013 |
| Countries | Argentina |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: